AbbVie Inc

Financials

Visión general Informes Estadísticas Dividendos

Activos totales 135.16 B136.16 B137.18 B133.9 B133.96 B Total de pasivos 157.57 B134.7 B137.32 B136.5 B164.87 B Capital total 3.36 B1.46 B-138 M-2.6 B-3.23 B Total de pasivos y patrimonio neto 135.16 B136.16 B137.18 B133.9 B133.96 B Deuda total 67.72 B———65.39 B Deuda neta 62.16 B———60.13 B

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'.

ABBV

Financials

AbbVie Inc

Noticias

AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider

Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)

Johnson & Johnson (JNJ) Surpasses Q1 Earnings and Revenue Estimates

J&J raises guidance for 2026 on strong start to the year

Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?

Wall Street Lunch: Netflix Draws Bullish Backing As Ad Revenue Seen Doubling To $3B

My Top 4 Pharma Picks Under Rising Geopolitical Risk

What's Going On With Eli Lilly Stock Monday? - Eli Lilly (NYSE:LLY)

Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1?

Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.

Haisco licencia candidatos a fármacos para el dolor a AbbVie por 745 millones de dólares

Fármaco de AbbVie para cáncer de ovario muestra tasa de respuesta del 62,7% en ensayo